SGS Expands Elemental Impurity Testing Services at its Laboratory in Chennai, IndiaAllbiopro2018-11-14T10:43:50+09:0011월 14th, 2018|
Dana-Farber Cancer Institute and Deerfield Collaborate to Create the Centre for Protein DegradationAllbiopro2018-11-14T10:43:23+09:0011월 14th, 2018|
Updated: BioSpace’s List of November 2018 Life Sciences IPOsAllbiopro2018-11-14T10:42:55+09:0011월 14th, 2018|
9 Quick Ways to Prepare for a Last-Minute Job InterviewAllbiopro2018-11-14T10:42:29+09:0011월 14th, 2018|
Resume Best Practices: 4 Things You Should Always Include in Your Employment History SectionAllbiopro2018-11-14T10:42:03+09:0011월 14th, 2018|
With $65 Million in Hand, Kymera Will Put Its Protein Degradation Technology to the TestAllbiopro2018-11-14T10:41:36+09:0011월 14th, 2018|
Nestlé Increases Stake in Aimmune as Company Eyes Filing for FDA Approval of Peanut Allergy MedicineAllbiopro2018-11-14T10:41:09+09:0011월 14th, 2018|
Ribometrix Launches With $30 Million to Develop RNA Structure-Based DrugsAllbiopro2018-11-14T10:40:42+09:0011월 14th, 2018|
Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardiovascular HealthAllbiopro2018-11-14T10:40:16+09:0011월 14th, 2018|
Pain Therapeutics Will Make the Case for an FDA Reversal on RemoxyAllbiopro2018-11-14T10:39:49+09:0011월 14th, 2018|
Active Ingredient of Marijuana May Help With Alzheimer’s … at Least If You’re a MouseAllbiopro2018-11-14T10:39:23+09:0011월 14th, 2018|
Deep Dive: Immunovative Therapies’ Next-Generation Cancer Vaccine Could Change the GameAllbiopro2018-11-14T10:38:56+09:0011월 14th, 2018|
Roivant Sciences Raises $200 Million, Bringing Its Valuation to $7 BillionAllbiopro2018-11-14T10:38:27+09:0011월 14th, 2018|
Machine learning for pharma marketers: The time is now to budget, experiment and adjust, expert saysAllbiopro2018-11-14T10:37:59+09:0011월 14th, 2018|
Roche’s Tecentriq blazes toward first-in-class breast cancer nod with FDA ‘priority’ tagAllbiopro2018-11-14T10:37:31+09:0011월 14th, 2018|
AstraZeneca offloads RSV drug to Sobi for $1.5B, its largest divestiture in 5 yearsAllbiopro2018-11-14T10:37:03+09:0011월 14th, 2018|
Bayer’s animal and consumer health units look weaker, yes. But don’t expect selloffs: CEOAllbiopro2018-11-14T10:36:36+09:0011월 14th, 2018|
AbbVie inks licensing deal to boost Mavyret access in nearly 100 countriesAllbiopro2018-11-14T10:36:08+09:0011월 14th, 2018|
